193 related articles for article (PubMed ID: 34862598)
21. The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.
Masarwy R; Shilo S; Carmel Neiderman NN; Kampel L; Horowitz G; Muhanna N; Mansour J
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173922
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Tumor Classifications for Cutaneous Squamous Cell Carcinoma of the Head and Neck in the 7th vs 8th Edition of the AJCC Cancer Staging Manual.
Karia PS; Morgan FC; Califano JA; Schmults CD
JAMA Dermatol; 2018 Feb; 154(2):175-181. PubMed ID: 29261835
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma.
Arron ST; Wysong A; Hall MA; Bailey CN; Covington KR; Kurley SJ; Goldberg MS; Kasprzak JM; Somani AK; Ibrahim SF; Brodland DG; Cleaver NJ; Maher IA; Xia Y; Koyfman SA; Newman JG
Laryngoscope Investig Otolaryngol; 2022 Feb; 7(1):135-144. PubMed ID: 35155791
[TBL] [Abstract][Full Text] [Related]
24. Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by Dermatologists.
Rebeca T; Giselle P; Litchman GH; Rigel DS
J Drugs Dermatol; 2019 Oct; 18(10):980-984. PubMed ID: 31584775
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the eighth edition of the TNM and Brigham Women's Hospital staging systems for cutaneous squamous cell carcinoma of the head and neck: a six-year review.
Bowe CM; Houlton S; Walsh S
Br J Oral Maxillofac Surg; 2020 Nov; 58(9):1158-1163. PubMed ID: 33071049
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
Que SKT; Zwald FO; Schmults CD
J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for metastatic cutaneous squamous cell carcinoma: Refinement and replication based on 2 nationwide nested case-control studies.
Tokez S; Venables ZC; Hollestein LM; Qi H; Bramer EM; Rentroia-Pacheco B; van den Bos RR; Rous B; Leigh IM; Nijsten T; Mooyaart AL; Wakkee M
J Am Acad Dermatol; 2022 Jul; 87(1):64-71. PubMed ID: 35259451
[TBL] [Abstract][Full Text] [Related]
28. Comparative Performance of Four Staging Classifications to Select «High-Risk» Head and Neck Cutaneous Squamous Cell Carcinomas.
Elaldi R; Chamorey E; Schiappa R; Sudaka A; Anjuère F; Villarmé A; Culié D; Bozec A; Montaudié H; Poissonnet G
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373623
[TBL] [Abstract][Full Text] [Related]
29. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of the 8th edition American Joint Commission Cancer (AJCC) nodal staging system for patients with cutaneous squamous cell carcinoma of the head and neck.
Liu J; Ebrahimi A; Low TH; Gao K; Palme CE; Sydney C; Ashford BG; Iyer NG; Clark JR; Gupta R
J Surg Oncol; 2018 Mar; 117(4):765-772. PubMed ID: 29049841
[TBL] [Abstract][Full Text] [Related]
31. Staging System Performance and Clinical Outcomes for Cutaneous Squamous Cell Carcinoma of the Ear: A Single-Center Retrospective Study.
Navarrete-Dechent C; Mori S; Connolly K; Shah K; Dusza SW; Rossi AM; Lee EH; Busam KJ; Nehal KS
Dermatol Surg; 2023 Aug; 49(8):747-754. PubMed ID: 37235869
[TBL] [Abstract][Full Text] [Related]
32. Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma.
Wysong A; Newman JG; Covington KR; Kurley SJ; Ibrahim SF; Farberg AS; Bar A; Cleaver NJ; Somani AK; Panther D; Brodland DG; Zitelli J; Toyohara J; Maher IA; Xia Y; Bibee K; Griego R; Rigel DS; Meldi Plasseraud K; Estrada S; Sholl LM; Johnson C; Cook RW; Schmults CD; Arron ST
J Am Acad Dermatol; 2021 Feb; 84(2):361-369. PubMed ID: 32344066
[TBL] [Abstract][Full Text] [Related]
33. AI-empowered cellular morphometric risk score improves prognostic stratification of cutaneous squamous cell carcinoma.
Pérez-Baena MJ; Mao JH; Pérez-Losada J; Santos-Briz Á; Chang H; Cañueto J
Clin Exp Dermatol; 2023 Aug; ():. PubMed ID: 37572359
[TBL] [Abstract][Full Text] [Related]
34. Definition of prognostic subgroups in the T3 stage of the eighth edition of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Tentative T3 stage subclassification.
Conde-Ferreirós A; Corchete LA; Puebla-Tornero L; Corchado-Cobos R; García-Sancha N; Román-Curto C; Cañueto J
J Am Acad Dermatol; 2021 Nov; 85(5):1168-1177. PubMed ID: 32278798
[TBL] [Abstract][Full Text] [Related]
35. Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system.
Schmitt AR; Brewer JD; Bordeaux JS; Baum CL
JAMA Dermatol; 2014 Jan; 150(1):19-24. PubMed ID: 24226651
[TBL] [Abstract][Full Text] [Related]
36. Metastatic Cutaneous Squamous Cell Carcinoma: The Importance of T2 Stratification and Hematologic Malignancy in Prognostication.
Stevenson ML; Kim R; Meehan SA; Pavlick AC; Carucci JA
Dermatol Surg; 2016 Aug; 42(8):932-5. PubMed ID: 27467226
[TBL] [Abstract][Full Text] [Related]
37. Identifying Brigham and Women's Hospital stage T2a cutaneous squamous cell carcinomas at risk of poor outcomes.
Gupta N; Weitzman RE; Murad F; Koyfman SA; Smile TD; Chang MS; Maher JM; Schmults CD; Vidimos AT; Ruiz ES
J Am Acad Dermatol; 2022 Jun; 86(6):1301-1308. PubMed ID: 34864111
[TBL] [Abstract][Full Text] [Related]
38. Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England.
Venables ZC; Autier P; Nijsten T; Wong KF; Langan SM; Rous B; Broggio J; Harwood C; Henson K; Proby CM; Rashbass J; Leigh IM
JAMA Dermatol; 2019 Mar; 155(3):298-306. PubMed ID: 30484823
[TBL] [Abstract][Full Text] [Related]
39. Analysis and comparison of the 7th edition American Joint Committee on Cancer (AJCC) nodal staging system for metastatic cutaneous squamous cell carcinoma of the head and neck.
Clark JR; Rumcheva P; Veness MJ
Ann Surg Oncol; 2012 Dec; 19(13):4252-8. PubMed ID: 22805870
[TBL] [Abstract][Full Text] [Related]
40. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics.
Farasat S; Yu SS; Neel VA; Nehal KS; Lardaro T; Mihm MC; Byrd DR; Balch CM; Califano JA; Chuang AY; Sharfman WH; Shah JP; Nghiem P; Otley CC; Tufaro AP; Johnson TM; Sober AJ; Liégeois NJ
J Am Acad Dermatol; 2011 Jun; 64(6):1051-9. PubMed ID: 21255868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
